Instead, how about objectively evaluating the products in the pipeline? The chart will not tell you the future sales figures for Medidur, but an analysis of trial results to date, market size and competing products might go some way towards a good estimate. The chart will also not tell you how much Pfizer will pay in milestone and royalty payments for PSD's drug delivery technology.
Pezz
- Forums
- ASX - By Stock
- PSD
- buyers looking strong
PSD
psivida limited
buyers looking strong, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online